{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T18:29:43Z","timestamp":1788805783243,"version":"build-2803163510"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T00:00:00Z","timestamp":1644192000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T00:00:00Z","timestamp":1644192000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Aesth Plast Surg"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s00266-021-02715-4","type":"journal-article","created":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T19:03:51Z","timestamp":1644260631000},"page":"1400-1406","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A Phase 3, Randomized, Multi-center Clinical Trial to Evaluate the Efficacy and Safety of Neu-BoNT\/A in Treatment of Primary Axillary Hyperhidrosis"],"prefix":"10.1007","volume":"46","author":[{"given":"Dong Geon","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Eun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woo Shun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moon-Bum","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-hun","family":"Huh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwang Seong","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jee-Bum","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Soo","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Kyung","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi Ryung","family":"Roh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyo Hyun","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won-serk","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Hee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kui Young","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weon Ju","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi Youn","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9822-4760","authenticated-orcid":false,"given":"Hoon","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,7]]},"reference":[{"key":"2715_CR1","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1111\/j.1365-2133.2007.07917.x","volume":"156","author":"DL Bovell","year":"2007","unstructured":"Bovell DL, Corbett AD, Holmes S, MacDonald A, Harker M (2007) The absence of apoeccrine glands in the human axilla has disease pathogenic implications, including axillary hyperhidrosis. Br J Dermatol 156:1278\u20131286","journal-title":"Br J Dermatol"},{"key":"2715_CR2","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1080\/09546634.2017.1309347","volume":"28","author":"JE Sammons","year":"2017","unstructured":"Sammons JE, Khachemoune A (2017) Axillary hyperhidrosis: a focused review. J Dermatolog Treat 28:582\u2013590","journal-title":"J Dermatolog Treat"},{"key":"2715_CR3","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.jaad.2003.12.029","volume":"51","author":"J Hornberger","year":"2004","unstructured":"Hornberger J, Grimes K, Naumann M et al (2004) Recognition, diagnosis, and treatment of primary focal hyperhidrosis. J Am Acad Dermatol 51:274\u2013286","journal-title":"J Am Acad Dermatol"},{"key":"2715_CR4","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1111\/j.1365-2133.2009.09248.x","volume":"161","author":"M Shibasaki","year":"2009","unstructured":"Shibasaki M, Davis SL, Cui J, Low DA, Keller DM, Crandall CG (2009) Botulinum toxin abolishes sweating via impaired sweat gland responsiveness to exogeneous acethylcholine. Br J Dermatol 161:757\u2013761","journal-title":"Br J Dermatol"},{"key":"2715_CR5","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0041-0101(00)00120-3","volume":"39","author":"M Adler","year":"2001","unstructured":"Adler M, Keller JE, Sheridan RE, Deshpande SS (2001) Persistence of botulinum neurotoxin A demonstrated by sequential administration of serotypes A and E in rat EDL muscle. Toxicon 39:233\u2013243","journal-title":"Toxicon"},{"key":"2715_CR6","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1152\/physrev.2000.80.2.717","volume":"80","author":"G Schiavo","year":"2000","unstructured":"Schiavo G, Matteoli M, Montecucco C (2000) Neurotoxins affecting neuroexocytosis. Physiol Rev 80:717\u2013766","journal-title":"Physiol Rev"},{"key":"2715_CR7","doi-asserted-by":"publisher","first-page":"335","DOI":"10.2340\/00015555-1464","volume":"93","author":"K Rosell","year":"2013","unstructured":"Rosell K, Hymnelius K, Swartling C (2013) Botulinum toxin type A and B improve quality of life in patients with axillary and palmar hyperhidrosis. Acta Derm Venereol 93:335\u2013339","journal-title":"Acta Derm Venereol"},{"key":"2715_CR8","first-page":"519","volume":"29","author":"TC Flynn","year":"2003","unstructured":"Flynn TC, Clark RE 2nd (2003) Botulinum toxin type B (MYOBLOC) versus botulinum toxin type A frontalis study: rate of onset and radius of diffusion. Dermatol Surg 29:519\u2013522","journal-title":"Dermatol Surg"},{"key":"2715_CR9","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.bjps.2004.07.003","volume":"58","author":"L Nelson","year":"2005","unstructured":"Nelson L, Bachoo P, Holmes J (2005) Botulinum toxin type B: a new therapy for axillary hyperhidrosis. Br J Plast Surg 58:228\u2013232","journal-title":"Br J Plast Surg"},{"key":"2715_CR10","doi-asserted-by":"publisher","first-page":"S68","DOI":"10.1002\/mds.20020","volume":"19","author":"MZ Atassi","year":"2004","unstructured":"Atassi MZ (2004) Basic immunological aspects of botulinum toxin therapy. Mov Disord 19:S68-84","journal-title":"Mov Disord"},{"key":"2715_CR11","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/dsu.12072","volume":"39","author":"CH Won","year":"2013","unstructured":"Won CH, Lee HM, Lee WS et al (2013) Efficacy and safety of a novel botulinum toxin type A product for the treatment of moderate to severe glabellar lines: a randomized, double-blind, active-controlled multicenter study. Dermatol Surg 39:171\u2013178","journal-title":"Dermatol Surg"},{"key":"2715_CR12","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1097\/PRS.0000000000001032","volume":"135","author":"JE Kim","year":"2015","unstructured":"Kim JE, Song EJ, Choi GS, Lew BL, Sim WY, Kang H (2015) The efficacy and safety of liquid-type botulinum toxin type A for the management of moderate to severe glabellar frown lines. Plast Reconstr Surg 135:732\u2013741","journal-title":"Plast Reconstr Surg"},{"key":"2715_CR13","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1080\/09638280701568296","volume":"29","author":"D Dressler","year":"2007","unstructured":"Dressler D, Benecke R (2007) Pharmacology of therapeutic botulinum toxin preparations. Disabil Rehabil 29:1761\u20131768","journal-title":"Disabil Rehabil"},{"key":"2715_CR14","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.toxicon.2010.12.019","volume":"57","author":"KH Eisele","year":"2011","unstructured":"Eisele KH, Fink K, Vey M, Taylor HV (2011) Studies on the dissociation of botulinum neurotoxin type A complexes. Toxicon 57:555\u2013565","journal-title":"Toxicon"},{"key":"2715_CR15","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/dsu.12070","volume":"39","author":"SB Kim","year":"2013","unstructured":"Kim SB, Ban B, Jung KS, Yang GH (2013) A pharmocodynamic comparison study of different botulinum toxin type A preparations. Dermatol Surg 39:150\u2013154","journal-title":"Dermatol Surg"},{"key":"2715_CR16","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3341\/kjo.2009.23.3.137","volume":"23","author":"JS Yoon","year":"2009","unstructured":"Yoon JS, Kim JC, Lee SY (2009) Double-blind, randomized, comparative study of Meditoxin versus Botox in the treatment of essential blepharospasm. Korean J Ophthalmol 23:137\u2013141","journal-title":"Korean J Ophthalmol"},{"key":"2715_CR17","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1093\/asj\/sjy207","volume":"39","author":"A da Costa","year":"2019","unstructured":"da Costa A, Pereira ESP, de Oliveira PM et al (2019) Six-month comparative analysis monitoring the progression of the largest diameter of the sweating inhibition halo of different botulinum toxins type-A. Aesthet Surg J 39:993\u20131004","journal-title":"Aesthet Surg J"},{"key":"2715_CR18","doi-asserted-by":"publisher","first-page":"2","DOI":"10.5070\/D394R5S9S1","volume":"18","author":"A Costa","year":"2012","unstructured":"Costa A, Pegas Pereira ES, de Oliveira PM et al (2012) Comparative study of the diffusion of five botulinum toxins type-A in five dosages of use: are there differences amongst the commercially-available products? Dermatol Online J 18:2","journal-title":"Dermatol Online J"},{"key":"2715_CR19","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.jaad.2007.01.009","volume":"56","author":"NJ Lowe","year":"2007","unstructured":"Lowe NJ, Glaser DA, Eadie N et al (2007) Botulinum toxin type A in the treatment of primary axillary hyperhidrosis: A 52-week multicenter, double-blind, randomized, placebo-controlled study of efficacy and safety. J Am Acad Dermatol 56:604\u2013611","journal-title":"J Am Acad Dermatol"},{"key":"2715_CR20","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1136\/bmj.323.7313.596","volume":"323","author":"M Naumann","year":"2001","unstructured":"Naumann M, Lowe NJ (2001) Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled trial. BMJ 323:596\u2013599","journal-title":"BMJ"},{"key":"2715_CR21","first-page":"43","volume":"4","author":"MS Nestor","year":"2011","unstructured":"Nestor MS, Ablon GR (2011) Duration of Action of Abobotulinum toxin A and Onabotulinum toxin A. J Clin Aesthet Dermatol 4:43\u201349","journal-title":"J Clin Aesthet Dermatol"},{"key":"2715_CR22","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.jaad.2019.11.042","volume":"82","author":"S Nawrocki","year":"2020","unstructured":"Nawrocki S, Cha JS (2020) Botulinum toxin: Pharmacology and injectable administration for the treatment of primary hyperhidrosis. J Am Acad Dermatol 82:969\u2013979","journal-title":"J Am Acad Dermatol"},{"key":"2715_CR23","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1046\/j.1365-2133.2001.04349.x","volume":"145","author":"P Schnider","year":"2001","unstructured":"Schnider P, Mararu E, Kittler H et al (2001) Treatment of focal hyperhidrosis with botulinum toxin type A: long-term follow-up in 61 patients. Br J Dermatol 145:289\u2013293","journal-title":"Br J Dermatol"}],"container-title":["Aesthetic Plastic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00266-021-02715-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00266-021-02715-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00266-021-02715-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T13:19:04Z","timestamp":1661433544000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00266-021-02715-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,7]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["2715"],"URL":"https:\/\/doi.org\/10.1007\/s00266-021-02715-4","relation":{},"ISSN":["0364-216X","1432-5241"],"issn-type":[{"value":"0364-216X","type":"print"},{"value":"1432-5241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,7]]},"assertion":[{"value":"20 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Woo Shun Lee is an employee of Medytox Inc., Korea. None of the others has a financial interest in any of the products, devices, or drugs mentioned in this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights"}},{"value":"This study was approved by the institutional review board of each institution and complied with all international and local rules for good clinical practice.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"All participants provided written informed consent to participate in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Participation"}}]}}